temozolomide has been researched along with folic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bigner, DD; Friedman, HS; Johnson, SP; Kamen, BA | 1 |
| Campion, L; Cartron, PF; Charbord, J; Debien, E; Hervouet, E; Menanteau, J; Vallette, FM | 1 |
| Amighi, K; Gelbcke, M; Mathieu, V; Rosière, R; Van Antwerpen, P; Wauthoz, N | 1 |
| Huang, J; Peng, Y; Shuai, X; Wu, T; Xiao, H | 1 |
| Emamgholizadeh Minaei, S; Karimi, MR; Khoee, S; Khoei, S | 1 |
| Khoee, S; Khoei, S; Mahabadi, VP; Minaei, SE; Vafashoar, F | 1 |
| Liu, JY; Ma, HD; Sui, L; Wang, LH; Wang, YL; Wei, Z; Zhao, PH | 1 |
| Afzalipour, R; Karimi, MY; Khoee, S; Khoei, S; Motevalian, M; Raoufi, NJ; Shirvalilou, S | 1 |
| Lim, T; Martinez-Morales, AA; Ortiz-Islas, E; Rodriguez-Perez, E; Uribe-Robles, M; Valverde, FF | 1 |
1 review(s) available for temozolomide and folic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for temozolomide and folic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
O (4)-benzylfolic acid inactivates O (6)-alkylguanine-DNA alkyltransferase in brain tumor cell lines.
Topics: Antineoplastic Agents, Alkylating; Binding, Competitive; Brain Neoplasms; Carrier Proteins; Cell Line, Tumor; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Inhibitory Concentration 50; O(6)-Methylguanine-DNA Methyltransferase; Receptors, Cell Surface; Temozolomide | 2007 |
Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferation.
Topics: Aged; Apoptosis; Apoptosis Regulatory Proteins; Becaplermin; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Dietary Supplements; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA Modification Methylases; DNA Repair Enzymes; Folic Acid; Gene Expression Regulation, Neoplastic; Glioma; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Middle Aged; Neoplasm Invasiveness; Platelet-Derived Growth Factor; Protein Binding; Proto-Oncogene Proteins c-sis; Repetitive Sequences, Nucleic Acid; Sp1 Transcription Factor; Sp3 Transcription Factor; Survival Analysis; Survivin; Temozolomide; Tumor Suppressor Proteins | 2009 |
New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy.
Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Cell Proliferation; Chemistry, Pharmaceutical; Dacarbazine; Dry Powder Inhalers; Folic Acid; Humans; Lung Neoplasms; Mice; Nanoparticles; Particle Size; Temozolomide | 2015 |
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Dacarbazine; Drug Carriers; Drug Delivery Systems; Folic Acid; Gene Silencing; Genes, bcl-2; Glioma; Humans; Micelles; Nanoparticles; Particle Size; Polyethylene Glycols; Polyethyleneimine; Polymers; Proton Magnetic Resonance Spectroscopy; Rats; RNA, Messenger; RNA, Small Interfering; Static Electricity; Temozolomide | 2018 |
Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma.
Topics: Animals; Biological Transport; Cell Line, Tumor; Drug Carriers; Folic Acid; Glioblastoma; Nanoparticles; Particle Size; Rats; Temozolomide | 2019 |
In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Folic Acid; Glioblastoma; Humans; Hyperthermia, Induced; Magnetics; Magnetite Nanoparticles; Temozolomide | 2019 |
Folate-modified Graphene Oxide as the Drug Delivery System to Load Temozolomide.
Topics: Animals; Antineoplastic Agents, Alkylating; Biological Availability; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Folic Acid; Graphite; Humans; Rats; Spectroscopy, Fourier Transform Infrared; Temozolomide | 2020 |
Thermosensitive magnetic nanoparticles exposed to alternating magnetic field and heat-mediated chemotherapy for an effective dual therapy in rat glioma model.
Topics: Animals; Folic Acid; Glioma; Magnetic Fields; Magnetite Nanoparticles; Rats; Temozolomide | 2021 |
Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO
Topics: Cell Line, Tumor; Folic Acid; Glioblastoma; Humans; Nanospheres; Temozolomide | 2023 |